Loading…
Thursday, October 3 • 10:20am - 10:40am
AI in Drug Discovery Today- Artificial and Augmented Intelligence in Early Drug Discovery

Sign up or log in to save this to your schedule and see who's attending!

Tweet Share
Artificial and Augmented Intelligence in Early Drug Discovery:
Drug discovery data continues to grow in size and diversity due to technological advances and automation. Correspondingly, opportunities are emerging for applying machine learning to classification, regression, clustering, prediction, and recommenders, in an effort to make each decision in the process more predictive. Examples are provided of where AI is being applied to support decision-making, ranging from imaging to medicinal chemistry to ‘omics, in addition to implications for changing our approach to data stewardship and data science as a discipline in the pharmaceutical industry.
Speakers
avatar for Jeremy Jenkins, PhD

Jeremy Jenkins, PhD

Executive Director, Novartis Institutes for BioMedical Research
Jeremy is Executive Director and Head of Data Science in Chemical Biology & Therapeutics at the Novartis Institutes for BioMedical Research. He joined Novartis 16 years ago, following a postdoc at Harvard Medical School and a PhD in Molecular Genetics from The Ohio State University... Read More →

Chairs
avatar for Yohann Potier, Ph.D.

Yohann Potier, Ph.D.

Director of Data Science & Informatics, Voyager Therapeutics
Yohann was recently named Director of Data Science & Informatics at Voyager Therapeutics, after almost six years at the Novartis Institute for Biomedical Research. He studied Biotechnology and Informatics in France followed by a Ph.D. in Computational Chemistry at the University of... Read More →

Thursday October 3, 2019 10:20am - 10:40am
Theater Ballroom (5th Fl) - Courtyard Boston Downtown 275 Tremont Street, Boston, MA 02116
  Session 1: AI in Drug Discovery Today

Attendees (1)